IP Library Granted Patent US 8,088,122
Granted Patent B2
US 8,088,122 · App. 11/828,236 · Granted Jan 3, 2012

Optical ear infection treatment device and method

Assignee: George Y. Choi
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,122
App. No.
11/828,236
Granted
Jan 3, 2012
Kind
B2
Abstract

Optical ear infection treatment device and methods are described where an LED and optical light pipe are used to deliver the light from the LED to the middle ear of a patient to reduce bacterial growth and/or eliminate bacteria. Typically, the device is placed in the ear and then activated by the user by pressing an activation button. Once activated the control electronics will turn on the LED and perform a treatment. The most basic treatment mode comprises turning on the LED at maximum power for a predetermined period, e.g. 30 minutes, 60 minutes. When the preset duration is completed, the device will notify the user by an audible beep or vibration that the treatment is complete. Once completed the user can remove the device, the treatment could be repeated once a day or for extreme cases multiple times during the day.

Claims (34)

1. A device for treating an ear infection in a user, comprising:

a light emitting diode;

a light pipe sized for placement directly within an ear canal and configured to transport light emitted from the light emitting diode to a middle ear region along a propagation path of less than 5 cm;

a control in electrical communication with the light emitting diode, wherein the control is operable by the user; and

an indicator for notifying the user of completion of a treatment.

2. The device of claim 1 wherein the light emitting diode is configured to emit light at a wavelength of 400 nm to 700 nm.

3. The device of claim 2 wherein the light emitting diode is configured to emit light at a wavelength of 400 nm to 500 nm.

4. The device of claim 2 wherein the light emitting diode is configured to emit light at a wavelength of 420 nm to 470 nm.

5. The device of claim 2 wherein the light emitting diode is configured to emit light at a wavelength of 500 nm to 700 nm.

6. The device of claim 1 wherein the device comprises a housing configured to attach to an ear of the user.

7. The device of claim 1 wherein the light pipe is comprised of a flexible and optically transparent polymer.

8. The device of claim 7 wherein the polymer comprises silicone.

9. The device of claim 7 wherein the light pipe comprises a central core having an index of refraction which is higher relative to an index of refraction of a cladding surrounding the central core.

10. The device of claim 9 wherein the cladding has a thickness of less than 100 microns.

11. The device of claim 1 wherein the light pipe further comprises a reflective coating to guide light from the light emitting diode through the light pipe.

12. The device of claim 11 wherein the reflective coating is comprised of aluminum or gold.

13. The device of claim 1 wherein the light pipe further comprises a biocompatible polymer coating.

14. The device of claim 1 wherein the light pipe defines a tapered tip configured to puncture through an ear drum of the user.

15. The device of claim 1 wherein the control comprises an actuator for manipulation by the user.

16. The device of claim 1 wherein the indicator is configured to vibrate to notify the user of completion of the treatment.

17. The device of claim 1 wherein the indicator is configured to emit an audible signal to notify the user of completion of the treatment.

18. The device of claim 1 wherein the control is configured to emit light from the light emitting diode for 20 minutes.

19. The device of claim 1 wherein the control is configured to emit light from the light emitting diode at an intensity of 250 J/cm 2 .

20. The device of claim 1 further comprising a power supply in electrical communication with the light emitting diode.

21. A device for treating an ear infection, comprising:

a light emitting diode;

a light pipe configured to transport light emitted from the light emitting diode along a propagation path of less than 5 cm to a middle ear region;

a control in electrical communication with the light emitting diode; and

an indicator for notifying a user of completion of a treatment.

22. The device of claim 21 wherein the light emitting diode is configured to emit light at a wavelength of 400 nm to 700 nm.

23. The device of claim 22 wherein the light emitting diode is configured to emit light at a wavelength of 400 nm to 500 nm.

24. The device of claim 22 wherein the light emitting diode is configured to emit light at a wavelength of 420 nm to 470 nm.

25. The device of claim 22 wherein the light emitting diode is configured to emit light at a wavelength of 500 nm to 700 nm.

26. The device of claim 21 wherein the device comprises a housing configured to attach to an ear of the user.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2007
From: LI, KASEY KAI-CHI; DA SILVA, LUIZ B.
To: CHOI, GEORGE YOSEUNG
Reel/Frame 020195/0943 →
Continuity (2)
Provisional Application 60838545 · Aug 17, 2006
Related Publication 20080097414A1 · Apr 24, 2008